Answers are grounded in this paper and cite their sources.
Betanin has potential for modulating lipid accumulation, but its biological activity depends on formulation and exposure conditions. We evaluated charge-modulated betanin liposomes in free fatty acid (FFA)-treated HepG2 cells and high-glucose-exposed Caenorhabditis elegans. Increasing DOTAP content from 0 to 30 mol% raised the zeta potential from −3.24 ± 0.12 to 31.09 ± 1.22 mV and the encapsulation efficiency from 35.21 ± 1.85% to 50.05 ± 1.70%. NBD-CL2 produced approximately 156-fold higher cell-associated fluorescence than NBD-CL0 in HepG2 cells, with higher fluorescence also observed descriptively in C. elegans. At the efficacy concentrations (25 μM betanin-equivalent in HepG2 cells and 50 μM in C. elegans), no apparent reduction in cell viability or survival was observed; pooled worm body-length measurements showed no overt change but did not support inference among independent exposure wells. In analyses accounting for experimental run, Bet-CL2 reduced Oil Red O intensity by 33.0% relative to the FFA-treated HepG2 group (n = 4 runs; Dunnett-adjusted p = 0.0061) and by 36.4% relative to the high-glucose C. elegans group (n = 3 runs; adjusted p = 0.017). These separate within-model results support attenuation of lipid accumulation in both models under the tested conditions, but do not establish cross-model statistical equivalence or superiority over free betanin or neutral liposomes. Carrier-associated fluorescence does not directly quantify betanin delivery. The dual-model approach supports complementary evaluation of carrier association and functional responses.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: